Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Tigason improved hair growth in a boy with monilethrix without side effects.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Tofacitinib may help treat hair loss in children with alopecia areata.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Upadacitinib effectively treats pyoderma gangrenosum.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Janus kinase inhibitors may help treat lichen planopilaris.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

JAK inhibitors show promise in treating difficult skin diseases.

Minoxidil caused a severe rash in a patient, which improved after stopping the drug.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

RCS-01 is safe and may help rejuvenate aging skin.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Tacrolimus ointment is effective for various skin conditions but needs more research for long-term effects.

Sorafenib can cause a unique skin reaction.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Nilotinib can cause skin issues like red bumps and hair loss.